Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

NCT02761993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Periodontal Disease

Interventions

BIOLOGICAL: ST266
DRUG: Saline (0.9% NaCl)

Sponsor

Noveome Biotherapeutics, formerly Stemnion